Immune-mediated necrotizing myopathy

Clinical trials for Immune-mediated necrotizing myopathy explained in plain language.

Never miss a new study

Get alerted when new Immune-mediated necrotizing myopathy trials appear

Sign up with your email to follow new studies for Immune-mediated necrotizing myopathy, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 7 Not yet recruiting 1 Not yet finished but already full! 3 Completed 1

Engineered immune cells take aim at autoimmune diseases

Disease control Not yet recruiting

This early-stage study is testing a new treatment called C-CAR168 for people with autoimmune diseases like multiple sclerosis, lupus, and myasthenia gravis that have not improved with standard therapies. The treatment uses a patient's own immune cells, which are modified in a lab…

Matched conditions: IMMUNE-MEDIATED NECROTIZING MYOPATHY

Phase 1 • Sponsor: The Affiliated Hospital of Qingdao University • Aim: Disease control

Last updated Jul 02, 2026 00:00 UTC

Immune-mediated necrotizing myopathy

Get alerted when new Immune-mediated necrotizing myopathy trials appear

Engineered immune cells take aim at autoimmune diseases